USC Schaeffer

Traditional Medicare now spends $55B annually on medical care for beneficiaries with #dementia, with costs expected to grow as the population ages. Our updated interactive data-viz makes it easy to explore how this spending has changed over two decades. schaeffer.usc.edu/research/demen…

USC Schaeffer’s Dima Qato discusses her pharmacy mapping tool, which reveals where access has collapsed and highlights how policymakers can combat pharmacy deserts. Her interview with @Drug_Topics ⤵️ drugtopics.com/view/how-pharm…

A deal to embed a Massachusetts health system’s clinics inside CVS is unlikely to boost primary care access while weakening price competition in important but hard-to-measure ways, USC Schaeffer's John Romley tells @medcitynews. medcitynews.com/2026/05/cvs-ma…

Declining civic participation is a threat to democracies worldwide, warns former UK PM Gordon Brown. As chair of USC Schaeffer’s new Center for Civic Society, he says a renewed commitment to building community is essential to bolstering democracy. 🔗schaeffer.usc.edu/research/renew…

USC Schaeffer's Geoffrey Joyce in the @nytimes discusses research suggesting that statins and drugs treating hypertension can reduce dementia risk. nytimes.com/2026/04/17/wel…

Mail-order pharmacy dispensing of mifepristone rose sharply after FDA lifted in-person requirements, now under Supreme Court review, USC Schaeffer researchers reported in @JAMA_current. schaeffer.usc.edu/research/abort…

The structural divide between #MedicareAdvantage drug coverage and standalone #PartD plans is widening under IRA cost pressures, according to research from USC Schaeffer's Geoffrey Joyce. academic.oup.com/healthaffairss…

A big obstacle to developing #Alzheimers treatments: slow & uneven trial recruitment. The USC Clinical Trial Recruitment Lab convened leaders to share strategies that speed recruitment, strengthen trust & ensure representative enrollment. Our report ⤵️ schaeffer.usc.edu/research/alzhe…

About 1 in 3 kids and teens use dietary supplements, despite limited evidence of their safety and effectiveness, USC Schaeffer’s Dima Mazen Qato finds in new research. healthday.com/healthday-tv/c…

There are often long delays between FDA approval and Medicare coverage of new devices. The agencies' plan to speed reimbursement for some devices could expand access to new technologies, USC Schaeffer’s William Padula told @FT. ft.com/content/9df3b2…

"Most-favored nation" has some drugmakers weighing whether to skip parts of Europe entirely, @business reports. USC Schaeffer’s Darius Lakdawalla says companies face a stark calculation: launching a treatment in Europe could end up halving the U.S. price. bloomberg.com/news/features/…

A value-based contracting approach proposed by USC Schaeffer offers a sustainable path to expanding Medicare access to GLP-1s. schaeffer.usc.edu/research/a-val…

To evaluate trends in inpatient & outpatient hospital care and the evolving composition of patients’ out-of-pocket cost sharing, @USCSchaeffer's Erin Duffy & coauthors look at 2021–22 data to shed light on the financial pressures on patients & providers. healthaffairs.org/doi/full/10.13…

Redesigning low-income neighborhoods may help reduce childhood obesity, a USC Schaeffer study suggests. 2 years into redevelopment of South LA’s Jordan Downs, obesity & overweigh rose 50% more slowly, kids were more active & they had fewer sugary drinks. schaeffer.usc.edu/research/publi…

Women aren’t just at higher risk of developing dementia—they’re also more likely to be caregivers, often unpaid. Dementia cost estimates from USC Schaeffer, cited in @TIME, highlight the staggering financial impact. time.com/article/2026/0…

New government data shows drug prices recently declined even as overall inflation increased. USC Schaeffer's William Padula in the @washingtonpost explains what's likely behind this shift. washingtonpost.com/wp-intelligenc…

A proposed rule to increase visibility into #PBM compensation is a key step toward stronger accountability, Schaeffer scholars wrote to DOL. Their letter outlines targeted changes to ensure the final rule delivers meaningful transparency. schaeffer.usc.edu/research/comme…

After the FDA lifted in-person dispensing requirements for mifepristone, less than 2% of pharmacy prescriptions were filled at retail locations, finds new USC Schaeffer research in @JAMA_current. schaeffer.usc.edu/research/abort…

The Center for Economic and Social Research (@CESRUSC), a global leader in generating data on how people live, work and make critical decisions, is joining the USC Schaeffer Institute and @USCPrice. schaeffer.usc.edu/research/cente…

Rising premiums are, in effect, a hidden pay cut for working families, writes USC Schaeffer's Glenn Melnick in @CalMatters. When employers spend more on health insurance, there is less money available for wages. calmatters.org/commentary/202…